Award
National Cancer Institute 5R37CA284132-04
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition
Recipient
University of Pennsylvania
Award Amount
$597,432.00
Ceiling
$597,432.00
Awarded
July 16, 2026
Identifier
5R37CA284132-04
Research project funded by NIH/NCI to study immune mechanisms and immunotherapy response in IDH-mutant glioma using human and murine models, awarded $597,432 for fiscal year 2026.
Description
This project involves research on immune mechanisms in IDH-mutant glioma, including immune profiling, genetic signatures, and response prediction to immunotherapy. It is funded by the NIH/NCI with a total award amount of $597,432 for the fiscal year 2026. The project is conducted at the University of Pennsylvania in Philadelphia, PA.